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Abstract
Background: Health care planning for chronic pelvic pain (CPP), an important cause of morbidity
amongst women is hampered due to lack of clear collated summaries of its basic epidemiological
data. We systematically reviewed worldwide literature on the prevalence of different types of CPP
to assess the geographical distribution of data, and to explore sources of variation in its estimates.
Methods: We identified data available from Medline (1966 to 2004), Embase (1980 to 2004),
PsycINFO (1887 to 2003), LILACS (1982 to 2004), Science Citation index, CINAHL (January 1980
to 2004) and hand searching of reference lists. Two reviewers extracted data independently, using
a piloted form, on participants' characteristics, study quality and rates of CPP. We considered a
study to be of high quality (valid) if had at least three of the following features: prospective design,
validated measurement tool, adequate sampling method, sample size estimation and response rate
>80%. We performed both univariate and multivariate meta-regression analysis to explore
heterogeneity of results across studies.
Results: There were 178 studies (459975 participants) in 148 articles. Of these, 106 studies were
(124259 participants) on dysmenorrhoea, 54 (35973 participants) on dyspareunia and 18 (301756
participants) on noncyclical pain. There were only 19/95 (20%) less developed and 1/45 (2.2%) least
developed countries with relevant data in contrast to 22/43 (51.2%) developed countries. Meta-
regression analysis showed that rates of pain varied according to study quality features. There were
40 (22.5%) high quality studies with representative samples. Amongst them, the rate of
dysmenorrhoea was 16.8 to 81%, that of dyspareunia was 8 to 21.8%, and that for noncyclical pain
was 2.1 to 24%.
Conclusion: There were few valid population based estimates of disease burden due to CPP from
less developed countries. The variation in rates of CPP worldwide was due to variable study quality.
Where valid data were available, a high disease burden of all types of pelvic pain was found.
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Background
Chronic pelvic pain (CPP) is a debilitating condition
among women with a major impact on health-related
quality of life, work productivity and health care utilisa-
tion. It is the single most common indication for referral
to women's health services accounting for 20% of all out-
patient appointments in secondary care [1]. This leads to
a substantial burden on limited health care resources. For
example, $881.5 million are spent per year on its outpa-
tient management in the USA [2] and an estimated £158
million are spent annually on the management of this
condition in the UK National Health Service [3].
Valid information about the true extent of CPP is an
essential consideration in resource allocation and health
care planning. In addition, these basic epidemiological
data are necessary to monitor trends of the disease burden
as well as to inform design of other research in this condi-
tion, like genetic and environmental epidemiology to
assess aetiology, qualitative studies to establish well being
and overall quality of life, and studies aimed at the devel-
opment of new treatment strategies [4]. The epidemiolog-
ical features of CPP have been generously reported in the
worldwide literature. The majority of the studies are lim-
ited by small sample size and hence their estimates are
imprecise. The need to summarise these data have gener-
ally received scant attention [5].
A systematic literature review was performed to ascertain:
the prevalence rates of CPP according to the type of pain;
its geographical distribution; its variation within sub-
groups defined by age and development status of the
country of origin; and the effect of study quality and rep-
resentativeness on the rates.
Methods
Our systematic review followed a protocol developed
using widely recommended methodology [6,7] and com-
plied with the MOOSE statement [8].
Data sources
We searched general bibliographic databases: Medline
(1966–2004), Embase (1980–2004) and PSYCHINFO
(1887–2004). We also searched specialist computer data-
bases: LILACS (Literatura Latinoamericana y del Caribe en
Ciencias de la Salud 1982 to 2004), CINAHL (January
1980 to 2004) and SCISEARCH (1974–2004). Our search
term combination for electronic databases was as follows:
MeSH headings, text words and word variants for "pelvic
pain" or "dysmenorrhoea" or "dyspareunia" or "low
abdominal pain" were combined using Boolean operator
and with terms like "prevalence" or "community survey"
or "incidence". These were combined with terms repre-
senting relevant study designs e.g. cross-section, survey
etc. according to recent recommendations [9] for search-
ing and the search was restricted to human and female.
We also hand searched the bibliographies of all relevant
reviews and primary studies to identify cited articles not
captured by electronic searches. The search did not have
any language restrictions. We also attempted to contact
authors from indexed electronic abstracts on theses for
data.
Study selection
Studies on CPP were selected using the following prede-
fined criteria:
Participants
Non-pregnant women without cancer participating in sur-
veys about rates of CPP. Women with or without known
endometriosis or irritable bowel syndrome were to be
included
Outcome
There is lack of consensus on the definition of CPP in the
published literature [10]. We used a definition based on
duration and nature of pain (constant or intermittent,
cyclical or noncyclical pain, that persisted for 3 months or
more [11]) and included three types: cyclical pain during
menstruation (dysmenorrhoea), deep dyspareunia and
noncyclical pelvic pain. Studies were included in the
absence of information on duration of pain as long as it
was explicit that cases of acute pain were excluded.
There is a debate about the definition of CPP as recurrent
pain such as that associated with isolated dysmenorrhoea
and dyspareunia is often considered biologically distinct
from chronic pain, however many women have overlap-
ping symptoms. For our review, CPP may be regarded as a
composite of chronic and recurrent pelvic pain.
Study design
Cross sectional studies that reported the prevalence of
CPP.
Data extraction and quality assessment
Two reviewers (PML, ML) extracted data independently,
using a piloted form, on participants' characteristics, study
quality and rates of CPP. Data on studies not published in
English were extracted by people with a medical back-
ground with command of the relevant language. In some
studies the existence of multiple symptoms amongst indi-
viduals could not be evaluated separately due to the struc-
ture of their questionnaires and their manner of reporting,
so these were excluded. Two of the datasets in the system-
atic review of dysmenorrhoea prevalence were extracted
from the abstracts of theses were when the full copies
could not be obtained [12,13].BMC Public Health 2006, 6:177 http://www.biomedcentral.com/1471-2458/6/177
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The methodological quality of all selected papers was
assessed to evaluate internal validity using the following
attributes [6]: (a) Study design to determine if CPP assess-
ment had been performed prospectively to minimise
recall bias; (b) Adequacy of sampling by assessing
whether recruitment of participants was random or con-
secutive or a convenience sample; (c) Sufficiently high
response rate (>80%); (d) Use of a validated measure-
ment tool to ascertain CPP [14] as this ensures that partic-
ipants' responses are a true representation of the
underlying condition; (e) Sample size calculation so as to
ascertain prevalence reliably. It was considered 'adequate'
if the studies had mentioned that sample size was calcu-
lated and 'inadequate' if this was not done or not men-
tioned explicitly. The studies were classified into high and
low quality groups based on compliance with 3/5 quality
criteria or more. Representativeness of the sample for gen-
eral population (source of sample) was considered sepa-
rately to methodological quality as this relates to external
validity. This distinction is important because internally
valid studies of women attending hospitals or for private
health care checks may not be biased but they are less use-
ful due to sampling of non-generalisable population
groups.
Numerators and denominators were extracted or esti-
mated from each study for computing rates and confi-
dence intervals (CI). In most studies, prevalence
measured how many women had CPP at a single point in
time, i.e. point prevalence [14]. Period prevalence, based
on the number of women developing CPP during a
defined period of time, was reported only in a few studies.
Data synthesis
For each study, we computed prevalence rates and their
95% CI according to the three different types of CPP.
Rates of the different CPP were mapped to depict the var-
iation in prevalence by country of origin. Heterogeneity
was explored in the log rates of CPP graphically using for-
est plots of point estimates of rates and their 95% CI and
statistically using Cochrane Q and I2, a statistic that quan-
tifies the degree of inconsistency across studies in a meta-
analysis on a scale ranging from 0–100% [15,16]. In
reviews with high degree of inconsistency meta-analysis is
not recommended. Meta-regression explored if inconsist-
ency in results across individual studies could be
explained by variations in countries' development status,
participants' age, representativeness of the sample and
methodological quality of the included studies [17]. For
development status we used the United Nations classifica-
tion (developed, less developed and least developed) for
countries. Study quality was assessed separately for indi-
vidual items and scores. We performed both univariate
and multivariate meta-regression analysis. We did not
pool results even from high quality representative studies
due to the statistically significant heterogeneity in this
subgroup of high quality representative studies. We how-
ever, have reported the rate ranges for representative stud-
ies [18]. Publication and related biases were examined for
by plotting log rates versus their corresponding variances
in a funnel plot. Funnel asymmetry was tested by Begg's
test [19].
Results
The electronic search yielded a total of 1226 citations (fig-
ure 1). On examination of titles and abstracts, 225 were
found to be potentially relevant and their full papers were
obtained. The reference lists of these revealed 32 further
citations. After reviewing these, 109 papers were excluded
(see additional file 3). The remaining 148 papers (see
additional file 2 for a complete list of included articles)
met the inclusion criteria, which provided data on
459972 participants. 30 studies overlapped and reported
more than one outcome or more than one group of pop-
ulation. There is very little data (1/148 papers) available
from the least developed countries. 22/43 developed
countries had published data on prevalence of CPP in
contrast to 19/95 less developed and 1/46 least developed
Study selection for systematic review on prevalence of  chronic pelvic pain Figure 1
Study selection for systematic review on prevalence of 
chronic pelvic pain.
Total citations identified from electronic searches 1226
Papers retrieved for detailed evaluation: 225
1001 Citations excluded after screening abstract
Papers excluded: 109
No/ Insufficient /unclear data 5 
Not a primary data source 19
Not on prevalence of pelvic pain 50
Duplicate data 9
Unobtainable 3
Study performed in : pregnant/postnatal women 8
: cancer 4 
: other specified disorders 7
: case-control study/case report  4
Primary papers included in systematic review: 148
178 studies (some papers  report more than one outcome/study):  
106 – dysmenorrhea
54 - dyspareunia 
18 -noncyclical CPP 
Searching of reference lists: 32BMC Public Health 2006, 6:177 http://www.biomedcentral.com/1471-2458/6/177
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countries (P < 0.0001) [the denominator is the number of
developed, less developed and least developed countries
in the world according to UN country classification].
Study quality assessment (figure 2) revealed deficiencies
in many areas of methodology: Two (1.2%) studies met
all five high quality criteria, 13 (7.1%) met 4/5 criteria
and 40 (22.5%) met three or more criteria.
The details of studies included in the systematic review on
prevalence of dysmenorrhoea, dyspareunia and noncycli-
cal pelvic pain are given in table 1, 2 and 3 respectively
(additional file 1). The data on prevalence of CPP in
included studies is summarised in figures 3, 4. Epimaps in
Figure 3 depict the available data by countries, on world-
wide prevalence of different types of chronic pelvic pain
by percentage.
Dysmenorrhoea
The prevalence rates ranged from 1.7% [2] to 97% [20] in
106 studies including 125249 women. Prevalence rates
for cyclical pelvic pain in the UK reported were between
45% (12% reporting severe dysmenorrhoea) [21] to 97%
[20] (14% severe) for any dysmenorrhoea in community
based studies and between 41–62% in hospital based
studies [22-24]. In other European countries it was similar
[25,26]. The lowest prevalence was reported in Bulgaria
(8.8%) in women hospitalised with adnexitis between the
ages of 19–41 years and the highest was in Finland (94%)
in girls aged 10–20 years [27]. In 20 high quality studies
with representative samples, the rate of dysmenorrhoea
was reported between 16.8 [28] to 81% [29]. There was
substantial heterogeneity in forest plots and I2 statistic was
98% (figure 4). The funnel plot for dysmenorrhoea was
asymmetrical (Begg's test P = 0.02; figure 5a) but not for
representative studies (P = 0.333). Metaregression (Table
4) showed validated measurement tool to be a significant
factor to explain heterogeneity but not study quality score,
representativeness, age < 25 years or development status
of the country (developed versus less developed versus
least developed).
Prevalence of different types of chronic pelvic pain Figure 4
Prevalence of different types of chronic pelvic pain.
Quality of studies included in systematic review on preva- lence of chronic pelvic pain Figure 2
Quality of studies included in systematic review on 
prevalence of chronic pelvic pain. (Data presented as 
100% stacked bars; figures in the stacks represent number of 
studies).
Epimaps of worldwide prevalence of chronic pelvic pain Figure 3
Epimaps of worldwide prevalence of chronic pelvic pain.
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Dyspareunia
The prevalence rates ranged from 1.3% [30] to 45.7% [31]
in 54 studies including 35973 women. The rates of dys-
pareunia varied from 1.1% in Sweden [32] to 45% [31] in
US studies. In 18 high quality studies with representative
samples, the rate range of dyspareunia was reported to be
8 [33] to 21.1 [34]% Studies were markedly heterogene-
ous (I2 = 97.9%) and the funnel plot for dyspareunia was
asymmetrical (Begg's test P = 0.001; figure 5b) but not in
representative studies (P = 0.227). The representativeness
of sample provided the main explanation for heterogene-
ity that was statistically significant in meta-regression
analysis (table 4) but age under 60 was not (P = 0.15).
Non-cyclical pelvic pain
The prevalence rates ranged from 4.0% [35] to 43.4% [36]
in 18 studies including 299740 women. Two recent stud-
ies stated a 3 month prevalence of 15% in women aged
18–50 years in the USA [2] and 24% in ages between 12–
70 in the UK [37]. In less developed countries in South
East Asia the prevalence rates varied from 5.2% in India,
8.8% in Pakistan to 43.2% in Thailand [36]. Amongst the
3 high quality studies with representative samples, the
rate range of noncyclical pain was 2.1 [37] to 24 [29]% as
reported from the primary studies. There was heterogene-
ity across studies (I2 = 99%). Metaregression (table 4)
revealed that prospective design, adequate sampling strat-
egy and sample size estimation tended to describe lower
prevalence of noncyclical pelvic pain though none of
these were significant (table 4). The funnel plot for non-
cyclical pelvic pain was asymmetrical (Begg's test P =
0.048; figure 5c) but not for representative studies (Begg's
test P = 0.88).
Discussion
This is the first systematic review of the worldwide preva-
lence of CPP. The variation in rates of CPP worldwide was
explained by variable study quality. The number of popu-
lation-based studies yielding estimates of burden of CPP
from less developed countries was low. High quality liter-
ature comprising representative samples revealed a high
burden of disease for all types of pelvic pain, however,
there remained heterogeneity in these subgroup of stud-
ies.
We believe that the findings of our study are valid as our
review methodology was rigorous. A prospective review
protocol was used and a concerted effort made to identify
all the available evidence without language restriction. We
made concerted efforts to report this systematic review as
suggested by the MOOSE consensus statement [8]. Both
the methodology and the rates of CPP varied among the
included primary studies and we explored the reasons for
variations comprehensively. This review represents the
best available evidence on the estimates of the prevalence
of CPP at the time of writing and rate ranges from high
quality studies of representative samples provide the best
information available for targeting services at women suf-
fering from pelvic pain.
The variation in geographical distribution may be related
to study characteristics, study quality, age groups included
and definitions used rather than intrinsic differences
between the prevalence of CPP between the different pop-
ulations. Other plausible explanations might be differ-
ences in the prevalence of sexually transmitted infections,
Funnel plots of the three types of pelvic pain prevalence stud- ies Figure 5
Funnel plots of the three types of pelvic pain preva-
lence studies. [a – dysmenorrhoea; b – dyspareunia; c – 
noncyclical pelvic pain]
Begg's funnel plot with pseudo 95% confidence limits
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availability of medical and other resources or cultural dif-
ferences. Although we have included studies from 1924
onwards, majority of the studies are from 1980 onwards.
The population demographics are unlikely to have under-
gone major changes over this period, making the studies
relevant to current populations' Nevertheless, one has to
bear in mind the changes in patterns of smoking, sexually
transmitted infections and contraception during this time
and their consequences for pelvic pain [38]. Substantial
differences in and even complete absence of definitions,
together with differences in age ranges of the populations
studied also complicate the interpretation of our findings.
One study noted the overlaps among different pain disor-
ders (irritable bowel syndrome, interstitial cystitis etc)
[39], A better understanding of the epidemiology of these
disorders would facilitate our understanding of somato-
sensory disorders in general. We explored for heterogene-
ity using sophisticated technique of metaregression. We
found that validated measurement tool, representative-
ness and high quality were the variables that were statisti-
cally significant (P < 0.05) for dysmenorrhoea,
dyspareunia and noncyclical pelvic pain respectively. In
the meta-regression for countries classification, there are
so few least developed countries that the power is very
low. Also, it is worth pointing out that there is a potential
risk of aggregation bias when age is used as a variable in
meta-regression.
The information on the rates of dysmenorrhoea, dyspare-
unia have implication for provision of services to policy-
makers in terms of provision of improved access for these
women to health care resources as well as the develop-
ment of appropriate treatment protocols. Future epidemi-
ological studies should ideally be prospective, with
explicit definitions of the outcome and representative of
the general population. Close attention must be paid to
study design and to the use the validated measurement
tools for validity and comparability of the results across
studies and regions. Such efforts will need funding agen-
cies to be willing to support broader and more systems
oriented approach [40].
Conclusion
There were few valid population based estimates of dis-
ease burden due to CPP from less developed countries.
The variation in rates of CPP worldwide was due to varia-
ble study quality. Where valid data were available, a high
disease burden of all types of pelvic pain was found.
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